Acute coronary syndrome in a patient with transient ischemic attack: challenges of antithrombotic therapy (a clinical case)
https://doi.org/10.14412/2074-2711-2019-4-156-159
Abstract
The paper presents experience with antithrombotic therapy in a critically ill patient with acute coronary syndrome and transient ischemic attack. It characterizes problems in triple antithrombotic therapy in a very ill patient with comorbidity. The paper demonstrates an incremental approach to choosing therapy according to the clinical picture of disease, an assessment of risk factors for ischemic and hemorrhagic complications over time, which is very important in the routine practice of a physician. It also shows how, based on existing recommendations, the optimal anticoagulant is chosen as part of triple and double antithrombotic therapy in terms of its potential risks and possible complications.
About the Authors
E. Yu. Kovalchuk
I.I. Dzhanelidze Saint Petersburg Research Institute of Emergency Medicine
Russian Federation
3A, Budapeshtskaya St., Saint Petersburg 192242
Russian Federation
3A, Budapeshtskaya St., Saint Petersburg 192242
A. S. Povzun
I.I. Dzhanelidze Saint Petersburg Research Institute of Emergency Medicine
Russian Federation
3A, Budapeshtskaya St., Saint Petersburg 192242
Russian Federation
3A, Budapeshtskaya St., Saint Petersburg 192242
V. A. Kostenko
I.I. Dzhanelidze Saint Petersburg Research Institute of Emergency Medicine
Russian Federation
3A, Budapeshtskaya St., Saint Petersburg 192242
Russian Federation
3A, Budapeshtskaya St., Saint Petersburg 192242
A. V. Brega
I.I. Dzhanelidze Saint Petersburg Research Institute of Emergency Medicine
Russian Federation
3A, Budapeshtskaya St., Saint Petersburg 192242
Russian Federation
3A, Budapeshtskaya St., Saint Petersburg 192242
References
1. Demograficheskii ezhednevnik Rossii. 2017 [Demographic diary of Russia. 2017]. Moscow: Rosstat; 2017. 100 p.
2. Boitsova SA, Samorodskaya IV, Starinskaya MA, et al. Analysis of the structure and dynamics of mortality from diseases of the circulatory system in Russia in 2006-2014. Profilakticheskaya meditsina. 2016;19(2-2):11-2. (InRuss.)
3. Towhsend N, Wilson L, Bhatnager P, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016 Nov 7; 37(42):3232-3245. Epub 2016 Aug 14.
4. Khenneritsi MG, Boguslavski Zh, Sakko RL. Insul't: klinicheskoe rukovodstvo. 2-e izd [Stroke: a Clinical guide . 2nd ed.]. Moscow: MEDpress-inform; 2008. 224 p.
5. Adams H, Bendixen B, Kappelle J, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke. 1993 Jan;24(1):35-41.
6. Gusev EI, Konovalov AN, Skvortsova VI, Gekht AB, redaktory. Nevrologiya. Natsional'noe rukovodstvo [Neurology. National guidelines]. Moscow: GEOTAR- Media; 2009. 1040 p.
7. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457-507. doi: 10.1159/000131083. Epub 2008 May 6.
8. Jauch EC, Saver JL, Adams HP Jr, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947. doi: 10.1161/STR.0b013e318284056a. Epub 2013 Jan 31.
9. Hacke W, Kaste M, Bluhmki E, et al; ECASS Investigators. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.
10. Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320. Epub 2015 Aug 29.
11. Konstantinides SV, Torbicki A, Agnelli G, et al. ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k. doi: 10.1093/eurheartj/ehu283. Epub 2014 Aug 29.
12. Bokeriya LA, Zatevakhin II, Kirienko AI, et al. Russian clinical guidelines for the diagnosis, treatment and prevention of venous thromboembolic complications (VTEC). Flebologiya. 2015;9(4-2):1-52. (InRuss.)
13. Cannon CP, Bhatt DL, Oldgren J, et al. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.
14. Instructions for use of the drug for medical use Xarelto] https://medi.ru/instrukciya/ksarelto-20_12600/
15. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Sep 17;361(12): 1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30.
16. Gibson CM, Mehran R, Bode C, et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016 Dec 22;375(25):2423-2434. doi: 10.1056/NEJMoa1611594. Epub 2016 Nov 14.
Review
For citations:
Kovalchuk EY, Povzun AS, Kostenko VA, Brega AV. Acute coronary syndrome in a patient with transient ischemic attack: challenges of antithrombotic therapy (a clinical case). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):156-159. (In Russ.) https://doi.org/10.14412/2074-2711-2019-4-156-159
Views:
513
Email this article 